Is digoxin still justifiable as single first-line therapy in fetal SVT associated with fetal hydrops?

Kersten, D; McDougall, J; Schuller, C; Pfammater, J; Raio, L; Meyer-Wittkopf, M; Surbek, D (2008). Is digoxin still justifiable as single first-line therapy in fetal SVT associated with fetal hydrops? Geburtshilfe und Frauenheilkunde, 68, S53. Stuttgart: Thieme

Full text not available from this repository. (Request a copy)

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology
UniBE Contributor:	Kersten, Dirk Jan, Schuller, Regine-Christine, Raio, Luigi, Meyer-Wittkopf, Matthias, Surbek, Daniel
ISSN:	0016-5751
Publisher:	Thieme
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 15:06
Last Modified:	05 Dec 2022 14:20
Web of Science ID:	000259577500216
URI:	https://boris.unibe.ch/id/eprint/28621 (FactScience: 122596)